How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation

被引：18

作者：

Perini, Guilherme Fleury ^{[1
,2
]}

Fischer, Thais ^{[3
]}

Gaiolla, Rafael Dezen ^{[4
]}

Rocha, Talita Bueno ^{[3
]}

Bellesso, Marcelo ^{[5
,6
]}

Cardoso Teixeira, Larissa Lane ^{[1
,7
]}

Delamain, Marcia Torresan ^{[2
,8
]}

de Souza Scheliga, Adriana Alves ^{[9
]}

Ribeiro, Glaciano Nogueira ^{[10
]}

Neto, Jorge Vaz ^{[11
]}

Carvalho Guimaraes Baiocchi, Otavio Cesar ^{[12
,13
]}

Ramires Abdo, Andre Neder ^{[5
,13
]}

Arrais-Rodrigues, Celso ^{[12
,14
]}

Fogliatto, Laura M. ^{[15
]}

Bigni, Ricardo de Sa ^{[16
]}

Schaffel, Rony ^{[17
]}

Biasoli, Irene ^{[17
]}

Pereira, Juliana ^{[5
]}

Nabhan, Samir Kanaan ^{[18
]}

de Souza, Carmino Antonio ^{[8
]}

Chiattone, Carlos Sergio ^{[19
,20
]}

机构：

[1] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil

[2] Amer Oncol, Sao Paulo, SP, Brazil

[3] AC Camargo Canc Ctr, Sao Paulo, SP, Brazil

[4] Hosp Clin Fac Med Botucatu HC FMB, Sao Paulo, SP, Brazil

[5] Inst Canc Sao Paulo, ICESP, Sao Paulo, SP, Brazil

[6] Hemomed, Sao Paulo, SP, Brazil

[7] Hosp Municipal Vila Santa Catarina, Sao Paulo, SP, Brazil

[8] Univ Estadual Campinas, UNICAMP, Campinas, SP, Brazil

[9] Grp Oncoclin CTO CEON, Rio De Janeiro, RJ, Brazil

[10] Hosp Clin Univ Fed Minas Gerais HC UFMG, Belo Horizonte, MG, Brazil

[11] Ctr Canc Brasilia CETTRO, Brasilia, DF, Brazil

[12] Hosp Alemao Oswaldo Cruz, Sao Paulo, SP, Brazil

[13] Univ Fed Sao Paulo, Unifesp, Sao Paulo, SP, Brazil

[14] Hosp Sirio Libanes, Sao Paulo, SP, Brazil

[15] Hosp Clin Porto Alegre HPCA, Porto Alegre, RS, Brazil

[16] Inst Nacl Canc INCA, Rio De Janeiro, RJ, Brazil

[17] Univ Fed Rio de Janeiro UFRJ, Rio De Janeiro, RJ, Brazil

[18] Univ Fed Parana UFPR, Curitiba, Parana, Brazil

[19] FCM Santa Casa Sao Paulo, Sao Paulo, SP, Brazil

[20] Hosp Samaritano Higienopolis, Sao Paulo, SP, Brazil

来源：

HEMATOLOGY TRANSFUSION AND CELL THERAPY | 2020年 / 42卷 / 02期

关键词：

CoVid; CoVId-19; Coronavirus; Lymphoma; Chronic lymphocytic leukemia; Lymphoid malignancies; STEM-CELL TRANSPLANTATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; BENDAMUSTINE PLUS RITUXIMAB; MANTLE-CELL; OPEN-LABEL; HODGKINS LYMPHOMA; T-CELL; BRENTUXIMAB VEDOTIN; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL;

D O I：

10.1016/j.htct.2020.04.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The novel Coronavirus (CoVid-19) outbreak is now consider a world pandemic, affecting more than 1,300,000 people worldwide. Cancer patients are in risk for severe disease, including a higher risk of intensive care unit (ICU) admission, need for invasive ventilation or death. Management of patients with lymphoid malignancies can be challenging during the outbreak, due to need of multiple hospital visits and admissions, immunosuppression and need for chemotherapy, radiotherapy and stem cell transplantation. In this article, we will focus on the practical management of patients with lymphoid malignancies during the COVID-19 pandemic, focusing on minimizing the risk for patients. (C) 2020 Published by Elsevier Editora Ltda. on behalf of Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular.

引用

页码：103 / 110

页数：8

共 64 条

[1]

[Anonymous], 2015, J CLIN ONCOL, DOI DOI 10.1111/BJH.13628

[2] Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study [J].

Bachy, Emmanuel ;

Seymour, John F. ;

Feugier, Pierre ;

Offner, Fritz ;

Lopez-Guillermo, Armando ;

Belada, David ;

Xerri, Luc ;

Catalano, John V. ;

Brice, Pauline ;

Lemonnier, Francois ;

Martin, Alejandro ;

Casasnovas, Olivier ;

Pedersen, Lars M. ;

Dorvaux, Veronique ;

Simpson, David ;

Leppa, Sirpa ;

Gabarre, Jean ;

da Silva, Maria G. ;

Glaisner, Sylvie ;

Ysebaert, Loic ;

Vekhoff, Anne ;

Intragumtornchai, Tanin ;

Le Gouill, Steven ;

Lister, Andrew ;

Estell, Jane A. ;

Milone, Gustavo ;

Sonet, Anne ;

Farhi, Jonathan ;

Zeuner, Harald ;

Tilly, Herve ;

Salles, Gilles .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) :2815-+

[3] Model-informed drug development approach supporting approval of the 4-week (Q4W) dosing schedule for nivolumab (Opdivo) across multiple indications: a regulatory perspective [J].

Bi, Y. ;

Liu, J. ;

Furmanski, B. ;

Zhao, H. ;

Yu, J. ;

Osgood, C. ;

Ward, A. ;

Keegan, P. ;

Booth, B. P. ;

Rahman, A. ;

Wang, Y. .

ANNALS OF ONCOLOGY, 2019, 30 (04) :644-651

[4] ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors [J].

Boleti, E. ;

Mead, G. M. .

ANNALS OF ONCOLOGY, 2007, 18 (02) :376-380

[5] When to treat patients with relapsed follicular lymphoma [J].

Cheah, Chan Yoon ;

Seymour, John F. .

EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (03) :187-191

[6] Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes? [J].

Chiappella, Annalisa ;

Crombie, Jennifer ;

Guidetti, Anna ;

Vitolo, Umberto ;

Armand, Philippe ;

Corradini, Paolo .

HEMASPHERE, 2019, 3 (05)

[7] Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma [J].

Connors, J. M. ;

Jurczak, W. ;

Straus, D. J. ;

Ansell, S. M. ;

Kim, W. S. ;

Gallamini, A. ;

Younes, A. ;

Alekseev, S. ;

Illes, A. ;

Picardi, M. ;

Lech-Maranda, E. ;

Oki, Y. ;

Feldman, T. ;

Smolewski, P. ;

Savage, K. J. ;

Bartlett, N. L. ;

Walewski, J. ;

Chen, R. ;

Ramchandren, R. ;

Zinzani, P. L. ;

Cunningham, D. ;

Rosta, A. ;

Josephson, N. C. ;

Song, E. ;

Sachs, J. ;

Liu, R. ;

Jolin, H. A. ;

Huebner, D. ;

Radford, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (04) :331-344

[8] Myeloid Growth Factors, Version 2.2017 Clinical Practice Guidelines in Oncology [J].

Crawford, Jeffrey ;

Becker, Pamela Sue ;

Armitage, James O. ;

Blayney, Douglas W. ;

Chavez, Julio ;

Curtin, Peter ;

Dinner, Shira ;

Fynan, Thomas ;

Gojo, Ivana ;

Griffiths, Elizabeth A. ;

Hough, Shannon ;

Kloth, Dwight D. ;

Kuter, David J. ;

Lyman, Gary H. ;

Mably, Mary ;

Mukherjee, Sudipto ;

Patel, Shiven ;

Perez, Lia E. ;

Poust, Adam ;

Rampal, Raajit ;

Roy, Vivek ;

Rugo, Hope S. ;

Saad, Ayman A. ;

Schwartzberg, Lee S. ;

Shayani, Sepideh ;

Talbott, Mahsa ;

Vadhan-Raj, Saroj ;

Vasu, Sumithira ;

Wadleigh, Martha ;

Westervelt, Peter ;

Burns, Jennifer L. ;

Pluchino, Lenora .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (12) :1520-+

[9] Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01 [J].

d'Amore, Francesco ;

Relander, Thomas ;

Lauritzsen, Grete F. ;

Jantunen, Esa ;

Hagberg, Hans ;

Anderson, Harald ;

Holte, Harald ;

Osterborg, Anders ;

Merup, Mats ;

Brown, Peter ;

Kuittinen, Outi ;

Erlanson, Martin ;

Ostenstad, Bjorn ;

Fagerli, Unn-Merete ;

Gadeberg, Ole V. ;

Sundstrom, Christer ;

Delabie, Jan ;

Ralfkiaer, Elisabeth ;

Vornanen, Martine ;

Toldbod, Helle E. .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) :3093-3099

[10] Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial [J].

Davies, Andrew ;

Merli, Francesco ;

Mihaljevic, Biljana ;

Mercadal, Santiago ;

Siritanaratkul, Noppadol ;

Solal-Celigny, Philippe ;

Boehnke, Axel ;

Berge, Claude ;

Genevray, Magali ;

Zharkov, Artem ;

Dixon, Mark ;

Brewster, Michael ;

Barrett, Martin ;

MacDonald, David .

LANCET HAEMATOLOGY, 2017, 4 (06) :E272-E282

← 1 2 3 4 5 6 7 →